Chloroquine Diphosphate in the Prevention of SARS in Covid-19 Infection

NCT04342650 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV Infection
Severe Acute Respiratory Syndrome (SARS) Pneumonia
Clinical Trial

Interventions

DRUG: Chloroquine Diphosphate
DRUG: Placebo oral tablet

Sponsor

Fundação de Medicina Tropical Dr. Heitor Vieira Dourado